In the latest trading session,, 1.33 million Sunshine Biopharma Inc (NASDAQ:SBFM) shares changed hands as the company’s beta touched 0.24. With the company’s most recent per share price at $1.54 changing hands around $0.09 or 6.21% at last look, the market valuation stands at $7.02M. SBFM’s current price is a discount, trading about -421.43% off its 52-week high of $8.03. The share price had its 52-week low at $1.17, which suggests the last value was 24.03% up since then. When we look at Sunshine Biopharma Inc’s average trading volume, we note the 10-day average is 59150.0 shares, with the 3-month average coming to 1.45 million.
Sunshine Biopharma Inc (NASDAQ:SBFM) trade information
Instantly SBFM is in green as seen in intraday trades today. With action 9.22%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -81.56%, with the 5-day performance at 9.22% in the green. However, in the 30-day time frame, Sunshine Biopharma Inc (NASDAQ:SBFM) is 8.45% up. Looking at the short shares, we see there were 94923.0 shares sold at short interest cover period of 0.92 days.
Sunshine Biopharma Inc (SBFM) estimates and forecasts
Year-over-year growth is forecast to reach 29.61% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 11.2M. 1 analysts are of the opinion that Sunshine Biopharma Inc’s revenue for the current quarter will be 12.1M. The company’s revenue for the corresponding quarters a year ago was 9.3M and 8.44M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 20.39%. The estimates for the next quarter sales put growth at 43.45%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 82.07%.
SBFM Dividends
Sunshine Biopharma Inc is expected to release its next quarterly earnings report on 2025-Apr-01.
Sunshine Biopharma Inc (NASDAQ:SBFM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.17% of Sunshine Biopharma Inc shares while 1.74% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.80%.
With 11.0 shares estimated at $17.0 under it, the former controlled 0.00% of total outstanding shares.
